More

    Novavax asks FDA for emergency authorization of its COVID-19 booster

    spot_img

    Novavax has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine as a booster in adults that can be used on top of the its primary vaccine series or to mix and match with a different primary series, the company announced.

    “It’s important for people to have a choice as they evaluate how to stay protected against COVID-19, and boosters are an invaluable tool to build upon immunity obtained from previous vaccinations,” Stanley C. Erck, President and Chief Executive Officer of Novavax, said in a statement on Monday.

    “Based on the data presented to the FDA’s VRBPAC and the CDC ACIP, we believe our vaccine offers a broad, long-lasting immune response against a range of variants,” Erck said.

    PHOTO: A box of the Novavax Covid-19 vaccine arranged at a pharmacy in Schwenksville, Pennsylvania, Aug. 1, 2022.

    A box of the Novavax Covid-19 vaccine arranged at a pharmacy in Schwenksville, Pennsylvania, Aug. 1, 2022.

    Hannah Beier/Bloomberg via Getty Images, FILE

    Although half a million doses of Novavax’s vaccine have now been distributed to states, following its authorization last month, just 9,700 doses of Novavax’s COVID-19 vaccine have been administered across the country, according to federal data.

    The sluggish start may be, in part, due to the fact that the vaccines were not immediately made available after authorization, and thus, there could be some reporting delays.

    Last month, officials from the Centers for Disease Control and Prevention signed off on the use of Novavax’s COVID-19 vaccine for Americans ages 18 years and older, making it the fourth COVID-19 vaccine to be made available to the American public.

    The Biden administration secured 3.2 million doses of Novavax’s COVID-19 vaccine.

    A number of health experts had expressed their hope that some of the individuals, who are still hesitant to be vaccinated, would be more inclined to get the Novavax vaccine, because it is based on a more traditional protein-based technology, one already used for the flu vaccine and other shots, while Pfizer and Moderna vaccine platforms tapped a new genetic technology — with messenger RNA — to produce their vaccines.

    Early indicators suggest that the authorization has yet to convince a large swath of the 26 million unvaccinated American adults to get the shot.

    PHOTO: A vial of the Novavax Covid-19 vaccine arranged at a pharmacy in Schwenksville, Pennsylvania, Aug. 1, 2022.

    A vial of the Novavax Covid-19 vaccine arranged at a pharmacy in Schwenksville, Pennsylvania, Aug. 1, 2022.

    Hannah Beier/Bloomberg via Getty Images, FILE

    However, experts say that although overall uptake may still be limited, there some Americans who have been vaccinated with Moderna, Pfizer, or Johnson & Johnson’s COVID-19 vaccines, may feel more inclined to receive Novavax’s booster.

    “Having vaccine options likely plays role in improving vaccination coverage. Given so many Americans have yet to receive their boosters despite the clear indication of their impact on reducing risk of severe complication from COVID-19, that improvement in vaccine uptake may be somewhat limited,” said John Brownstein, Ph.D., an epidemiologist at Boston Children’s Hospital and an ABC News contributor.

    Across the country, 110 million Americans — or more than half of those eligible to be boosted — have yet to receive their first booster shot, according to data from the CDC.

    Similarly, although over 61 million people, over the age of 50, are eligible to receive their second COVID-19 booster shot, just a third of people have actually done so.

    Source link

    Share

    All countries
    704,753,890
    Total confirmed cases
    Updated on February 15, 2025 8:17 pm
    Italy
    26,723,249
    Total confirmed cases
    Updated on February 15, 2025 8:17 pm
    Spain
    13,914,811
    Total confirmed cases
    Updated on February 15, 2025 8:17 pm
    Iran
    7,627,186
    Total confirmed cases
    Updated on February 15, 2025 8:17 pm
    Germany
    38,828,995
    Total confirmed cases
    Updated on February 15, 2025 8:17 pm

    Latest Updates

    Frequently Asked Questions

    spot_img

    Related Articles

    The 2023 Covid spike is easing in some areas, wastewater testing suggests

    Wastewater data suggest that the recent uptick in Covid cases may have peaked, at...

    Free at-home Covid tests return next week, Biden administration says

    Starting next week, people will be able to once again request four free Covid...

    FDA clears new Covid boosters: 5 things to know

    The Food and Drug Administration earlier this month greenlighted updated Covid boosters from Pfizer...

    New Covid vaccine rollout hampered by canceled appointments, insurance issues

    Some people seeking the newest Covid vaccines are running into high demand, insurance headaches...